Zimmer Biomet Holdings Inc (NYSE: ZBH) on Tuesday, plunged -0.04% from the previous trading day, before settling in for the closing price of $119.05. Within the past 52 weeks, ZBH’s price has moved between $102.00 and $147.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -1.20%. The company achieved an average annual earnings per share of 7.24%. With a float of $205.45 million, this company’s outstanding shares have now reached $205.60 million.
The extent of productivity of a business whose workforce counts for 18000 workers is very important to gauge.
Zimmer Biomet Holdings Inc (ZBH) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Zimmer Biomet Holdings Inc is 0.13%, while institutional ownership is 92.08%. The most recent insider transaction that took place on Mar 07 ’24, was worth 216,296. In this transaction Group President, Asia Pacific of this company sold 1,705 shares at a rate of $126.86, taking the stock ownership to the 18,179 shares. Before that another transaction happened on Feb 22 ’24, when Company’s Sr. VP/Gen Counsel/Secretary sold 26,156 for $128.62, making the entire transaction worth $3,364,126. This insider now owns 44,145 shares in total.
Zimmer Biomet Holdings Inc (ZBH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 7.24% per share during the next fiscal year.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Trading Performance Indicators
Zimmer Biomet Holdings Inc (ZBH) is currently performing well based on its current performance indicators. A quick ratio of 0.80 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.29. Likewise, its price to free cash flow for the trailing twelve months is 27.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.62, a number that is poised to hit 1.99 in the next quarter and is forecasted to reach 8.71 in one year’s time.
Technical Analysis of Zimmer Biomet Holdings Inc (ZBH)
The latest stats from [Zimmer Biomet Holdings Inc, ZBH] show that its last 5-days average volume of 1.05 million was inferior to 1.43 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 27.55%. Additionally, its Average True Range was 2.02.
During the past 100 days, Zimmer Biomet Holdings Inc’s (ZBH) raw stochastic average was set at 12.20%, which indicates a significant decrease from 22.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.04% in the past 14 days, which was lower than the 18.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $123.89, while its 200-day Moving Average is $119.22. Now, the first resistance to watch is $119.46. This is followed by the second major resistance level at $119.93. The third major resistance level sits at $120.18. If the price goes on to break the first support level at $118.74, it is likely to go to the next support level at $118.49. The third support level lies at $118.02 if the price breaches the second support level.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Key Stats
Market capitalization of the company is 24.48 billion based on 205,728K outstanding shares. Right now, sales total 7,394 M and income totals 1,024 M. The company made 1,889 M in profit during its latest quarter, and 172,400 K in sales during its previous quarter.
